InvestorsHub Logo
Followers 4
Posts 1198
Boards Moderated 0
Alias Born 10/03/2015

Re: willyw post# 1122

Thursday, 10/22/2015 9:35:44 AM

Thursday, October 22, 2015 9:35:44 AM

Post# of 3022
Which one is a better combo for the US market? Can it be decided without real world data?

1. Not pan-genotype regiment
12 week treatment => 95% SVR12 rate in GT1 TE, cirrhotic subgroups
8 week treatment => 100% SVR12 rate in GT1 TN
6 week treatment => 90% SVR12 rate in GT1 TN

2. pan-genotype regiment
12 week treatment => 94% SVR12 rate in GT1 TE, cirrhotic subgroups
8 week treatment => 98% SVR12 rate in GT1 TN
12 week treatment => 92% SVR12 rate in GT3 TE, cirrhotic subgroups
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News